GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity Por Kati GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity Read More »
Impact of Anthracyclines in Genomic High Risk, Node-Negative, HR-Positive/HER2-Negative Breast Cancer Por Adson Machado Impact of Anthracyclines in Genomic High Risk, Node-Negative, HR-Positive/HER2-Negative Breast Cancer Read More »
Iodine Seed−Marking Protocol for Response-Guided Axillary TreatmentAfter Systemic Therapy for Node-Positive Breast Cancer Por Adson Machado Iodine Seed−Marking Protocol for Response-Guided Axillary TreatmentAfter Systemic Therapy for Node-Positive Breast Cancer Read More »
Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay Por Adson Machado Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay Read More »
Biology is Queen: The Oncotype DX 21‑Gene Recurrence ScoreHas Stronger Prognostic Ability than Lymph Node Burdenfor Patients with Breast Cancer Por Adson Machado Biology is Queen: The Oncotype DX 21‑Gene Recurrence ScoreHas Stronger Prognostic Ability than Lymph Node Burdenfor Patients with Breast Cancer Read More »
Patritumab deruxtecan in HR+HER2−advanced breast cancer: a phase 2 trial Por Kati Patritumab deruxtecan in HR+HER2−advanced breast cancer: a phase 2 trial Read More »
Axillary dissection is avoidable in most cT1N0 triple‑negative & HER2+breast cancers treated with upfront surgery Por Kati Axillary dissection is avoidable in most cT1N0 triple‑negative & HER2+breast cancers treated with upfront surgery Read More »
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risktriple-negative early breast cancer patients Por Kati A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risktriple-negative early breast cancer patients Read More »
Axillary surgery in early breast cancer: real-world analysis of theINSEMA-trial at three certified university breast cancer centers in Germanyregarding the omission of sentinel lymph node biopsy Por Kati Axillary surgery in early breast cancer: real-world analysis of theINSEMA-trial at three certified university breast cancer centers in Germanyregarding the omission of sentinel lymph node biopsy Read More »
Impact of a Weight Loss Intervention on 1-Year Weight Changein Women With Stage II/III Breast Cancer Por Kati Impact of a Weight Loss Intervention on 1-Year Weight Changein Women With Stage II/III Breast Cancer Read More »
The impact of radiotherapy on trials of axillary management in early breastcancer Por Kati The impact of radiotherapy on trials of axillary management in early breastcancer Read More »
Brain Imaging Surveillance for Patients With MetastaticBreast Cancer: A Randomized Clinical Trial Is Requiredto Guide Practice Por Kati Brain Imaging Surveillance for Patients With MetastaticBreast Cancer: A Randomized Clinical Trial Is Requiredto Guide Practice Read More »